Oral 4: Growth

[O4-1] A reversible albumin-binding once-weekly growth hormone (GH) treatment (somapacitan; NNC0195-0092) induces a dose-dependent IGF-I response similar to daily GH therapy in children with growth hormone deficiency (GHD)

Tadej Battelino¹, ^○Michael Højby Rasmussen², Jean de Schepper³, Nehama Zuckerman-Levin⁴, Zoran Gucev⁵, Lars Sävendahl⁶ (1.Faculty of Medicine, University of Ljubljana, 2.Global Development, Novo Nordisk A/S, 3.Division of Paediatric Endocrinology, Universitair Ziekenhuis Brussel, 4.Pediatric and Obesity Clinic, Rambam Medical Center, 5.University Paediatrics Clinic, Medical Faculty Skopje, 6.Department of Women’s and Children’s Health, Karolinska Universitetssjukhuset)